{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:48:22Z","timestamp":1792813702101,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/cji.0b013e3181c0c1cb","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:34:39Z","timestamp":1268890479000},"page":"236-249","source":"Crossref","is-referenced-by-count":50,"title":["Intratumoral Interleukin-21 Increases Antitumor Immunity, Tumor-infiltrating CD8+ T-cell Density and Activity, and Enlarges Draining Lymph Nodes"],"prefix":"10.1097","volume":"33","author":[{"given":"Henrik","family":"S\u00f8ndergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth D.","family":"Galsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bartholomaeussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Thor","family":"Straten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"\u00d8dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kresten","family":"Skak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210208","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"R2-2-20210208","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"R3-2-20210208","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pages","year":"2005","journal-title":"N Engl J Med"},{"key":"R4-2-20210208","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","article-title":"Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection","volume":"25","author":"Gao","year":"2007","journal-title":"J Clin Oncol"},{"key":"R5-2-20210208","first-page":"3491","article-title":"CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer","volume":"58","author":"Naito","year":"1998","journal-title":"Cancer Res"},{"key":"R6-2-20210208","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/0008-5472.CAN-06-3388","article-title":"High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer","volume":"67","author":"Piersma","year":"2007","journal-title":"Cancer Res"},{"key":"R7-2-20210208","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-2-20210208","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1073\/pnas.0611618104","article-title":"CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma","volume":"104","author":"Sharma","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-2-20210208","first-page":"3932","article-title":"Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas","volume":"61","author":"Schumacher","year":"2001","journal-title":"Cancer Res"},{"key":"R10-2-20210208","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med"},{"key":"R11-2-20210208","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R12-2-20210208","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-065X.2006.00442.x","article-title":"Immune resistance orchestrated by the tumor microenvironment","volume":"213","author":"Gajewski","year":"2006","journal-title":"Immunol Rev"},{"key":"R13-2-20210208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function","volume":"408","author":"Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"R14-2-20210208","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","article-title":"Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells","volume":"179","author":"Bryant","year":"2007","journal-title":"J Immunol"},{"key":"R15-2-20210208","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1074\/jbc.M705100200","article-title":"IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner","volume":"282","author":"Wei","year":"2007","journal-title":"J Biol Chem"},{"key":"R16-2-20210208","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1084\/jem.20020620","article-title":"Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells","volume":"196","author":"Wurster","year":"2002","journal-title":"J Exp Med"},{"key":"R17-2-20210208","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.173.1.68","article-title":"T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells that provide help for B cells","volume":"173","author":"Chtanova","year":"2004","journal-title":"J Immunol"},{"key":"R18-2-20210208","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.4049\/jimmunol.178.5.2827","article-title":"IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine Production","volume":"178","author":"Coquet","year":"2007","journal-title":"J Immunol"},{"key":"R19-2-20210208","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1084\/jem.20062206","article-title":"IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses","volume":"203","author":"Harada","year":"2006","journal-title":"J Exp Med"},{"key":"R20-2-20210208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","article-title":"Interleukin-21: basic biology and implications for cancer and autoimmunity","volume":"26","author":"Spolski","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"R21-2-20210208","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nri1688","article-title":"Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation","volume":"5","author":"Leonard","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R22-2-20210208","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1158\/1078-0432.CCR-08-2663","article-title":"Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial","volume":"15","author":"Davis","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R23-2-20210208","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-07-0410","article-title":"An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma","volume":"13","author":"Davis","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R24-2-20210208","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00262-008-0479-4","article-title":"IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma","volume":"57","author":"Frederiksen","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"R25-2-20210208","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00262-007-0285-4","article-title":"Interleukin 21 therapy increases the density of tumor infiltrating CD8(+)T cells and inhibits the growth of syngeneic tumors","volume":"56","author":"Sondergaard","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"R26-2-20210208","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00262-008-0455-z","article-title":"Local therapy of cancer with free IL-2","volume":"57","author":"Den","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"R27-2-20210208","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2482","article-title":"Interleukin 21: combination strategies for cancer therapy","volume":"7","author":"Skak","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"R28-2-20210208","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/sj.bjc.6601320","article-title":"Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases","volume":"89","author":"Radny","year":"2003","journal-title":"Br J Cancer"},{"key":"R29-2-20210208","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ijc.10777","article-title":"Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo","volume":"103","author":"Scheffer","year":"2003","journal-title":"Int J Cancer"},{"key":"R30-2-20210208","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00002371-199911000-00007","article-title":"Cytokine depot formulations as adjuvants for tumor vaccines. I. Liposome-encapsulated IL-2 as a depot formulation","volume":"22","author":"Krup","year":"1999","journal-title":"J Immunother"},{"key":"R31-2-20210208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.coi.2005.01.011","article-title":"Breaking tolerance in cancer immunotherapy: time to ACT","volume":"17","author":"Overwijk","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R32-2-20210208","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1074-7613(02)00295-9","article-title":"IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity","volume":"16","author":"Kasaian","year":"2002","journal-title":"Immunity"},{"key":"R33-2-20210208","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J Exp Med"},{"key":"R34-2-20210208","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/intimm\/dxm093","article-title":"IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells","volume":"19","author":"Liu","year":"2007","journal-title":"Int Immunol"},{"key":"R35-2-20210208","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.175.4.2261","article-title":"IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response","volume":"175","author":"Li","year":"2005","journal-title":"J Immunol"},{"key":"R36-2-20210208","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.0806494","article-title":"IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade","volume":"82","author":"Ostiguy","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R37-2-20210208","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4049\/jimmunol.173.2.900","article-title":"IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21","volume":"173","author":"Moroz","year":"2004","journal-title":"J Immunol"},{"key":"R38-2-20210208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood-2007-05-089375","article-title":"IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes","volume":"111","author":"Li","year":"2008","journal-title":"Blood"},{"key":"R39-2-20210208","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm942","article-title":"Ex vivo identification, isolation and analysis of tumor-cytolytic T cells","volume":"9","author":"Rubio","year":"2003","journal-title":"Nat Med"},{"key":"R40-2-20210208","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.172.3.1540","article-title":"IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.","volume":"172","author":"Di Carlo","year":"2004","journal-title":"J Immunol"},{"key":"R41-2-20210208","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.juro.2006.04.037","article-title":"Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response","volume":"176","author":"Furukawa","year":"2006","journal-title":"J Urol"},{"key":"R42-2-20210208","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2006.09.053","article-title":"A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells","volume":"132","author":"Caruso","year":"2007","journal-title":"Gastroenterology"},{"key":"R43-2-20210208","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1189\/jlb.1107778","article-title":"The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells","volume":"84","author":"Wuest","year":"2008","journal-title":"J Leukoc Biol"},{"key":"R44-2-20210208","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4049\/jimmunol.178.2.732","article-title":"IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes","volume":"178","author":"Peluso","year":"2007","journal-title":"J Immunol"},{"key":"R45-2-20210208","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/mt.2008.249","article-title":"Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment","volume":"17","author":"Kim-Schulze","year":"2008","journal-title":"Mol Ther"},{"key":"R46-2-20210208","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"R47-2-20210208","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4049\/jimmunol.171.2.608","article-title":"IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma","volume":"171","author":"Ma","year":"2003","journal-title":"J Immunol"},{"key":"R48-2-20210208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.cgt.7700552","article-title":"Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts","volume":"10","author":"Ugai","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"R49-2-20210208","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.cgt.7700630","article-title":"Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects","volume":"10","author":"Ugai","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"R50-2-20210208","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.4049\/jimmunol.180.12.7958","article-title":"IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes","volume":"180","author":"Gagnon","year":"2008","journal-title":"J Immunol"},{"key":"R51-2-20210208","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1182\/blood-2007-09-113050","article-title":"IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy","volume":"111","author":"Hinrichs","year":"2008","journal-title":"Blood"},{"key":"R52-2-20210208","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/intimm\/dxn059","article-title":"IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes","volume":"20","author":"Ferrari-Lacraz","year":"2008","journal-title":"Int Immunol"},{"key":"R53-2-20210208","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","article-title":"Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis","volume":"173","author":"Jin","year":"2004","journal-title":"J Immunol"},{"key":"R54-2-20210208","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-07-5530","article-title":"Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses","volume":"68","author":"Iuchi","year":"2008","journal-title":"Cancer Res"},{"key":"R55-2-20210208","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jgm.817","article-title":"Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma","volume":"8","author":"Nakano","year":"2006","journal-title":"J Gene Med"},{"key":"R56-2-20210208","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/ijc.22901","article-title":"Glioma immunotherapy by IL-21 gene-modified cells or by recombinant IL-21 involves antibody responses","volume":"121","author":"Daga","year":"2007","journal-title":"Int J Cancer"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e3181c0c1cb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:20:22Z","timestamp":1786040422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-201004000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181c0c1cb","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}